<DOC>
	<DOCNO>NCT00060736</DOCNO>
	<brief_summary>This study evaluate effect mood stop estrogen replacement therapy . The purpose study investigate effect estrogen level perimenopausal depression . This study examine short-term withdrawal estrogen woman whose mood improve estrogen therapy . Perimenopause-related mood disorder cause significant distress large number woman . Evidence suggest estradiol may beneficial effect woman perimenopausal depression . However , effect decline estradiol secretion perimenopause fully examine . Peri- post-menopausal woman experience remission perimenopause-related depression symptom estrogen therapy control group healthy volunteer hormone replacement therapy ( HRT ) switch current form HRT estradiol 3-week period ; volunteer also complete symptom rating confirm absence mood symptom . Participants randomly assign either continue estradiol take placebo ( inactive pill ) additional 3 week . Mood rating use determine response estradiol withdrawal .</brief_summary>
	<brief_title>The Effects Estrogen Withdrawal Mood Symptoms Women</brief_title>
	<detailed_description>Perimenopause-related mood disorder cause significant distress large number woman . Recent study report therapeutic benefit estradiol woman mood disorder ; however , relevant pathophysiologic role decline estradiol secretion perimenopause demonstrate . In protocol wish investigate effect acute withdrawal estradiol mood placebo control condition . Thus , mood behavior symptom may precipitate experimental condition protocol . This protocol address follow hypothesis : woman past history perimenopause-related depression woman without history experience recurrence mood behavioral symptom acute estradiol withdrawal continue estradiol administration . The nature relationship decline secretion estradiol mood perimenopausal depress woman examine follow : Peri- postmenopausal woman report onset depression perimenopause report remission depressive symptom estrogen therapy ( ET ) withdrawn ET blind placebo-controlled condition . We recruit comparison group asymptomatic woman hormone replacement without history perimenopause-related depression . During three week baseline phase , woman switch current form hormone replacement therapy estradiol complete symptom rating confirm absence mood symptom prior entry study . After screen , woman randomize receive either estradiol placebo additional three week . Comparison mood rating contrast treatment condition allow u examine specific role estrogen withdrawal depression responsive ET .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>INCLUSION CRITERIA : All subject protocol either selfreferred response newspaper advertisement refer personal physician . The woman participate protocol previously complete screen protocol # 88M0131 , therefore , presence absence perimenopausal menopausal reproductive status evaluate document . 1 . Women past perimenopauserelated depression ( within 12 year ) whose depression respond ET recruit participate randomize , paralleldesign , doubleblind , placebocontrolled study . Women histories either perimenopausal depression responsive ET hormone replacement therapyinduced dysphoria due either estrogen progesterone component hormone replacement exclude . The diagnosis perimenopauserelated depression base history past depressive episode ( major minor depression confirm Structured Clinical Interview DSMIV ( SCID ) Schedule Affective Disorders SchizophreniaLifetime Version ( SADSL ) , respectively ) midlife association menstrual cycle irregularity history remission ( also confirm SCID SADSL ) depression ET . Additionally , woman report place HRT treatment perimenopausal symptom , include depression . 2 . Age 45 65 3 . In good medical health &lt; TAB &gt; Women without past perimenopausal depression To control effect hormonal manipulation protocol , also recruit group asymptomatic control either currently ET prescribe ET previously previous history perimenopauserelated depression HRTinduced dysphoria . Women participate study asymptomatic comparison group meet follow criterion : 1 . Women receive hormone therapy ( HT ) previous history perimenopauserelated depression HTinduced dysphoria 2 . No current mood behavioral problem 3 . Age 45 65 4 . In good medical health EXCLUSION CRITERIA : 1. past history severe major depression suicidal ideation 2. current treatment antidepressant medication 3. history ischemic cardiac disease , pulmonary embolism , thrombophlebitis 4. renal disease 5. hepatic dysfunction 6. woman history carcinoma breast 7. woman history uterine cancer , illdefined pelvic lesion , particularly undiagnosed ovarian enlargement , undiagnosed vaginal bleeding 8. pregnant woman 9. cerebrovascular disease ( stroke ) 10. recurrent migraine headache</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 27, 2016</verification_date>
	<keyword>Hormone Replacement</keyword>
	<keyword>Gonadal Steroids</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Minor Depression</keyword>
	<keyword>Perimenopause</keyword>
	<keyword>Estradiol</keyword>
	<keyword>Depression</keyword>
	<keyword>Perimenopausal Depression</keyword>
</DOC>